Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael L. Jones currently holds 16,653 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael L. Jones has been a net seller of BCRX stock. They have purchased $0 and sold $156.3K worth of shares.
Michael L. Jones's most recent insider trade was on Dec 19, 2022, when they sold 5,900 shares at $0.00 per share.
Michael L. Jones serves as Executive at BIOCRYST PHARMACEUTICALS INC (BCRX). They have executed 11 insider transactions totaling $156.3K over their tenure at the company.
Michael L. Jones holds the position of Executive at BIOCRYST PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Michael L. Jones has shown a selling trading pattern, with $0 in total purchases and $156.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael L. Jones was on Dec 1, 2022, when they sold $111.9K worth of BCRX shares. This transaction involved 8,600 shares at $13.01 per share.
Michael L. Jones currently owns 16,653 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael L. Jones's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael L. Jones has 11 Form 4 filings on record as an insider at BIOCRYST PHARMACEUTICALS INC.
Set alerts for Michael L. Jones and 40,000+ other insiders.